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I. Project ID, Project Description, Data Use Restrictions. 
 
This manuscript is part of a pilot effort on the part of NIH staff and the Nature publishing group 
to provide a more convenient archive for publication of "marker papers".  "Marker papers" are 
designed to provide the users of community resource data sets with information regarding the 
status and scope of individual community resource projects.  For further information, see 
editorial in the September 2010 edition of Nature Genetics (Nature Genetics, 42, 729 (2010)), 
and the Nature Precedings HMP summary page. 
 
Project IDs:  46877 (http://www.ncbi.nlm.nih.gov/genomeprj/46877)  
46311 (http://www.ncbi.nlm.nih.gov/genomeprj/46311) 
 
Data Use Restrictions. There is a 12 month publication moratorium on all data from this project 
deposited prior to January 7, 2011.  Data deposited into NCBI after that date have instructions 
to Hold Until Publication (HUP). The data will be held under the HUP for a period of 6 months or 
until we publish a manuscript including them, whichever is sooner. After that, the data will be 
released without any restrictions on use or publication. If you are interested in seeing the data 
sooner than the release date below, please contact us directly. It is expected that those using 
these data after release will respect the principles outlined in the 2003 Fort Lauderdale meeting 
(http://www.genome.gov/Pages/Research/WellcomeReport0303.pdf) with regard to 
acknowledging the source of the data. 
 
Description of Data Date of 
Deposition 
Length of time 
being held 
16S sequence data (454 Titanium platform) from 306 samples from 
the mid-vaginal wall, cervix, introitus, perianum and buccal cavity 
01/07/2011 6 months 
Clinical metadata from 1039 research participants at dbGAP 01/07/2011 6 months 
 
Project Description. The vagina is an interactive interface between the host and the 
environment. Its surface is covered by a protective epithelium colonized by bacteria and other 
microorganisms. The ectocervix is nonsterile, whereas the endocervix and the upper genital 
tract are assumed to be sterile in healthy women. Therefore, the cervix serves a pivotal role as 
a gatekeeper to protect the upper genital tract from microbial invasion and subsequent 
reproductive pathology. Microorganisms that cross this barrier can cause preterm labor, pelvic 
inflammatory disease, and other gynecologic and reproductive disorders. Homeostasis of the 
microbiome in the vagina and ectocervix plays a paramount role in reproductive health. 
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Depending on its composition, the microbiome may protect the vagina from infectious or non-
infectious diseases, or it may enhance its susceptibility to them. Because of the nature of this 
organ, and the fact that it is continuously colonized by bacteria from birth to death, it is virtually 
certain that this rich environment evolved in concert with its microbial flora. Specific interactions 
dictated by the genetics of both the host and microbes are likely responsible for maintaining 
both the environment and the microbiome. However, the genetic basis of these interactions in 
both the host and the bacterial colonizers is currently unknown. Lactobacillus species are 
associated with vaginal health, but the role of these species in the maintenance of health is not 
yet well defined. Similarly, other species, including those representing minor components of the 
overall flora, undoubtedly influence the ability of potential pathogens to thrive and cause 
disease. Gross alterations in the vaginal microbiome are frequently observed in women with 
bacterial vaginosis, but the exact etiology of this disorder is still unknown.  There are also 
implications for vaginal flora in non-infectious conditions such as pregnancy, pre-term labor and 
birth, and possibly fertility and other aspects of women’s health. Conversely, the role of 
environmental factors in the maintenance of a healthy vaginal microbiome is largely unknown. 
To explore these issues, we have proposed to address the following questions: 
 
1. Do genes of the host contribute to the composition of the vaginal microbiome? We 
hypothesize that genes of both host and bacteria have important impacts on the vaginal 
microbiome. We are addressing this question by examining the vaginal microbiomes of mono- 
and dizygotic twin pairs selected from the over 170,000 twin pairs in the Mid-Atlantic Twin 
Registry (MATR). Subsequent studies, beyond the scope of the current project, may 
investigate which host genes impact the microbial flora and how they do so. 
2. What changes in the microbiome are associated with common non-infectious 
pathological states of the host? We hypothesize that altered physiological (e.g., pregnancy) 
and pathologic (e.g., immune suppression) conditions, or environmental exposures (e.g., 
antibiotics) predictably alter the vaginal microbiome. Conversely, certain vaginal microbiome 
characteristics are thought to contribute to a woman’s risk for outcomes such as preterm 
delivery.  We are addressing this question by recruiting study participants from the ~40,000 
annual clinical visits to women’s clinics of the VCU Health System. 
3. What changes in the vaginal microbiome are associated with relevant infectious 
diseases and conditions? We hypothesize that susceptibility to infectious disease (e.g. 
HPV, Chlamydia infection, vaginitis, vaginosis, etc.) is impacted by the vaginal microbiome. In 
turn, these infectious conditions clearly can affect the ability of other bacteria to colonize and 
cause pathology. Again, we are exploring these issues by recruiting participants from visitors 
to women’s clinics in the VCU Health System. 
 
Three kinds of sequence data are generated in this project: i) rDNA sequences from vaginal 
microbes; ii) whole metagenome shotgun sequences from vaginal samples; and iii) whole 
genome shotgun sequences of bacterial clones selected from vaginal samples. The study 
includes samples from three vaginal sites: mid-vaginal, cervical, and introital.  The data sets 
also include buccal and perianal samples from all twin participants. Samples from these 
additional sites are used to test the hypothesis of a per continuum spread of bacteria in relation 
to vaginal health. An extended set of clinical metadata associated with these sequences are 
deposited with dbGAP. We have currently collected over 7,00 samples from more than 1,000 
twins and clinical participants. We have analyzed and deposited data for 786 rDNA samples, 
eight whole metagenome shotgun samples, and over 50 bacterial genomes. These data are 
available to accredited investigators according to NIH and Human Microbiome Project (HMP) 
guidelines. The bacterial clones are deposited in the Biodefense and Emerging Infections 
Research Resources Repository (http://www.beiresources.org/).  
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In addition to the extensive sequence data obtained in this study, we are collecting metadata 
associated with each of the study participants. Thus, participants are asked to complete an 
extensive health history questionnaire at the time samples are collected. Selected clinical data 
associated with the visit are also obtained, and relevant information is collected from the 
medical records when available. This data is maintained securely in a HIPAA-compliant data 
system as required by VCU’s Institutional Review Board (IRB). The preponderance of these 
data (i.e., that judged appropriate by NIH staff and VCU’s IRB are deposited at dbGAP 
(http://www.ncbi.nlm.nih.gov/gap). Selected fields of this data have been identified by NIH staff 
as ‘too sensitive’ and are not available in dbGAP. Individuals requiring access to these data 
fields are asked to contact the PI of this project or NIH Program Staff.   
 
II. Data Quality: 
 
Metagenomic 16S rDNA Sequencing. Our metagenomic rDNA sequences are generated from 
the PCR amplified V1-V3 (E. coli rDNA coordinates: 27-534) region of the bacterial small 
subunit rRNA gene from DNA isolated from swab samples taken from the mid-vaginal wall, 
cervix, introitus, perianum and buccal cavity of twin participants from the Mid-Atlantic Twin 
Registry, or from visitors to women’s clinics at the VCU Health Center. The amplified products 
are sequenced using Roche 454 Titanium technology. The 16S rDNA post-sequencing analysis 
pipeline is designed to filter the reads based on quality, to trim the barcode (Multiplex Identifier) 
and PCR amplification primer sequences, and to assign taxonomy to the high quality reads 
obtained. Our analysis pipeline retains those reads for which: i) a valid PCR primer and barcode 
is detected; ii) less than 10% of base calls have a quality score below Q10 iii); average quality of 
the bases in the read exceeds Q20; and iv) the read includes more than 200 but less than 540 
bases. Approximately 80% of the reads are retained after the application of these quality control 
metrics. These high quality reads are assigned taxonomy using the RDP Classifier (1) with a 
minimum bootstrap confidence of 80%. Additional analyses are also applied to specific subsets 
of reads to identify operational taxonomic units (OTUs).  
 
Whole Metagenome Shotgun Sequencing. Whole metagenome shotgun sequencing; i.e., 
shotgun sequencing of unamplified total DNA in a sample, is applied to selected vaginal 
samples from twin and clinical participants as described above. Reads for data that pass 
minimum quality standards for 454 Titanium sequencing are subjected to a preliminary screen 
(BLASTN with 1E-20 E-value cutoff and at least 90% sequence identity to the National Center 
for Biotechnology Information reference human genome build 37) to identify and filter reads 
from human DNA prior to submission to National Center for Biotechnology Information SRA 
Protected Database. Taxonomic content and metabolic potential of these samples is assessed 
as described below. 
 
Bacterial Clone Sequencing. Bacteria of interest are cultured and colony cloned from vaginal 
samples showing distinctive microbiome profiles. DNA is isolated using standard laboratory 
protocols and submitted for sequencing on the Illumina GAIIX or Roche 454 Titanium 
Sequencer. Sequences are assembled using Velvet (2), Newbler (Roche Diagnostics) or other 
appropriate assembler. Sequences of these bacterial clones will meet or exceed ‘Standard 
Draft’ quality as defined in Chain et al. (3). We have compared the complete genome 
sequences from a panel of Gardnerella vaginalis (4), Lactobacillus sp., Sneathia, and other 
isolates (in preparation), taken from our samples. 
 
III. Data Analysis and Publication Plans:   
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Metagenomic 16S rDNA taxonomic analysis. The 16S rDNA reads are binned using both 
taxonomic approaches and operational taxonomic units (OTUs) as described above. These data 
are then analyzed using a variety of methods. First, an assessment of experimental variation 
through the analysis of technical replicates is conducted so that true differences in the samples 
can be correctly confirmed. We then use visualization techniques such as variations of principal 
component analysis (PCA) (4) and stacked bar plots to compare microbiome profiles in samples 
based on abundant taxa in samples. We are developing statistical techniques for confirming that 
groups of samples arise from different distributions. Machine learning techniques and 
techniques grounded in measurement theory are used to identify the organisms/functional 
groups in microbiome profiles that correlate with clinical metadata. Longitudinal analyses are 
also being conducted to assess effects of the time in cycle on the microbiome.  Experiments are 
planned to quantify any bias introduced in the 16S rDNA analysis pipeline. 
 
Analysis of whole metagenome shotgun sequence data. After removal of ‘contaminating’ human 
sequence (see above), analysis of data from whole metagenome shotgun sequencing is 
performed in two different dimensions: taxonomic content and metabolic potential. Taxonomic 
content, which is intended to be compared to that derived from 16S studies, is analyzed by 
similarity searches (BLASTX [5], 1E-6 cutoff) of the filtered reads against the NR database at 
the National Center for Biotechnology Information, followed by analysis with MEGAN (6). 
Metabolic potential is being analyzed using ASGARD (7) in combination with UniProt (8) and 
KEGG (9) data to generate lists of functional entities and putatively present pathways, as well 
as graphical metabolic maps comparing different samples.  
 
Analysis of bacterial genome sequences. Interesting bacterial clones are sequenced and 
assembled as described above. Genes are called using a variety of gene calling packages. 
Metabolic reconstructions and genome comparisons are performed using ASGARD in 
combination with UniProt or KEGG data. Genomes are compared to existing reference 
genomes, when available, and to genomes of related bacterial isolated from relevant samples; 
e.g., mono- or dizygotic twins, microbiomes with unexpected or unusual profiles, etc. 
 
Twin Studies. The VCU twin microbiome study is targeting 250-350 pairs of adult female mono- 
and dizygotic twins ascertained through the population-based Mid-Atlantic Twin Registry 
(“MATR”). This sample, unselected for clinical history, will be supplemented by twin pairs 
ascertained to enrich the representation of significant clinical outcomes. Microbial samples from 
multiple body sites are obtained and characterized for twin participants, supplemented by 
metadata gathered by supervised self-report questionnaire obtained at the time of clinic visit.  A 
variety of univariate and multivariate techniques for genetic analysis of twin data have been 
developed and will be applied to the microbial data to: i) estimate the contributions of genetic 
and environmental factors to differences in prevalence of individual taxa at specific sites; ii) 
identify clusters of bacterial taxa whose co-occurrence depends on shared genetic or 
environmental risk factors in the host; iii) test for genetic and environmental factors that have a 
general effect on the composition of the microbiome across different sites; iv) identify specific 
environmental factors in the metadata that account for non-genetic differences with monozygotic 
twin pairs; v) test for the interaction of genetic effects in the host with specific environmental 
exposure on aspects of the human microbiome (genotype-environment interaction); vi) identify 
intermediate behavioral pathways (e.g. sexual behavior, substance use) that mediate the 
influence of the host genotype through differential exposure to environmental risk (genotype-
environment correlation). 
 
Publication Plans. Consortium participants anticipate publication of papers describing the 
general approaches and methodology employed in this project, general data relevant to the 
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specific aims of the project, and specific findings relevant to the specific milestones and 
objectives of the participants. Our analyses of these data will be published as soon as 
reasonably possible following its generation, in general, prior to the publication moratorium end 
dates. In some cases; e.g., variance components analysis of mono- and dizygotic twin data, 
analyses will be delayed until sufficient numbers of twin pairs have been recruited for the study. 
Thus, whereas preliminary data could be published with a suboptimal number of twin pairs, we 
will adopt a conservative approach to ensure that the conclusions are meaningful and valid. 
Therefore, to avoid compromising the final product and thus doing compromising the long term 
objectives of NIH in funding this project, we request that individuals planning to use our data in 
publications first consult with the PI of the project before beginning their analysis.  
 
IV. Data Release Plan: 
 
The VCU Vaginal Microbiome Consortium ascribes to NIH standard data release polices for 
rapid release of sequencing data such as that generated in this project. The policies are 
summarized in several web sites; e.g., NIAID policy is found at: 
http://www3.niaid.nih.gov/research/resources/mscs/data.htm; General NIH guidelines: 
http://grants.nih.gov/grants/policy/data_sharing/; http://www.genome.gov/10506376. 
Metagenomic rDNA sequence and whole metagenome sequence data from vaginal samples, 
and whole genome shotgun data from selected bacterial clones will be deposited in the short 
read archives at National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.gov/Traces/sra/sra.cgi). Metadata associated with these samples will 
be released to appropriate investigators through dbGAP (http://www.ncbi.nlm.nih.gov/gap). As 
described above, NIH has requested that certain particularly sensitive fields of the metadata not 
be released with the standard metadata files. Individuals requiring access to these data are 
encouraged to contact NIH or the PI of the project.    
 
V. Contact Person: 
 
Dr. Gregory A. Buck, Virginia Commonwealth University, Richmond, Virginia; email: 
gabuck@vcu.edu; phone: (804) 828-2318. 
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